Immunotherapies for Life

SC 13D

SEC Filing Details

Document Details

Filing Date
Oct 2, 2018
Document Date
Oct 2, 2018
Form Description
Filing by person(s) reporting owned shares of common stock in a public company >5%
Filing Group
3,4,5
Company
Y-mAbs Therapeutics, Inc.
Issuer
Y-mAbs Therapeutics, Inc.